Evidence map›Paper›PMID 19575556›Full record

ReviewAnnual review of microbiology2009

How sweet it is! Cell wall biogenesis and polysaccharide capsule formation in Cryptococcus neoformans.

Tamara Lea Doering

Open access · greenAbstract readReview
In one paragraph

Review in Annual review of microbiology, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 140 papers.

0numbers the graph read from it
0cells of the map it votes in
140citing papers in PubMed
6.9field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

140 citing papers in PubMed, 217 citations in OpenAlex.

  1. Article
  2. Acetylation and accessibility ofCell surface (Amsterdam, Netherlands) · 2026
    Article
  3. Review
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Evolutionary uniqueeLife · 2025
    Article
  12. Review
  13. Effects of human immunoglobulin A onMicrobiology spectrum · 2025
    Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. A Quick reCAP: DiscoveringJournal of fungi (Basel, Switzerland) · 2024
    Article
  19. Measuring Urease and Phospholipase Secretion in Cryptococcus neoformans.Methods in molecular biology (Clifton, N.J.) · 2024
    Article
  20. Article

80 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author at 1 institution in 1 country.

Tamara Lea DoeringDepartment of Molecular Microbiology, Washington University Medical School, St. Louis, Missouri, USA. doering@wustl.edu
Washington University in St. Louis · US

Funding

GLYCAN BIOSYNTHESIS IN CRYPTOCOCCUS NEOFORMANSR01GM071007 · NIGMS · WASHINGTON UNIVERSITY · PI DOERING, TAMARA L · 2004 to 2010
$1.9M
Polysaccharide capsule export in the fungal pathogen Cryptococcus neoformansR21AI073380 · NIAID · WASHINGTON UNIVERSITY · PI DOERING, TAMARA L · 2007 to 2008
$408k
NIAID NIH HHS R21 AI073380NIGMS NIH HHS R01 GM071007PHS HHS R01-071007PHS HHS R21-073380
6 · The paper itself

Abstract

Cryptococcus neoformans is a pathogenic fungus responsible for severe opportunistic infections. The most prominent feature of this yeast is its elaborate polysaccharide capsule, a complex structure that is required for virulence. The capsule is intimately associated with the cell wall, which underlies the capsule and offers the organism strength and flexibility in potentially hostile environments. Both structures are primarily composed of polysaccharides, offering a glimpse of the tremendous variation inherent in natural carbohydrate structures and their multiple biological functions. The steps in cell wall and capsule biosynthesis and assembly pose fascinating questions of metabolism, enzymology, cell biology, and regulation; the answers have potential application to treatment of a deadly infection. This article reviews current knowledge of cryptococcal cell wall and capsule biosynthesis and outstanding questions for the future.

Indexed as

Cell WallCryptococcus neoformansHumansModels, BiologicalPolysaccharidesVirulencePolysaccharides

Identifiers

PMID19575556
PMCPMC2880894
OpenAlexW2115040899

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.